FDA grants Yale OCR ‘Safe to Proceed’ notices

The Office of Cooperative Research at Yale University has
announced that the FDA has granted “Safe to Proceed” notices to two separate Investigational New Drug applications to conduct human studies of two novel therapeutic agents: AN19 (a thyroid hormone agonist, also known as Sobetirome or GC-1) and YPT-01 (a bacteriophage). Yale University holds the intellectual property on both investigational drugs.